Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Tacromus 1 mg Capsule
Manufacturer/Marketed By : Cadila Healthcare Ltd
$4.96 $3.34
Tacromus 1 mg capsule is an immunosuppressive medication specifically designed to help prevent organ rejection in transplant patients. By dampening the immune response, Tacromus works in conjunction with other treatments...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Tacrolimus 1 mg
Active Pharmaceutical Ingredient
Tacromus 1 mg Capsule
4,96 $US
3,34 $US
Tacromus 1 mg capsule is an immunosuppressive medication specifically designed to help prevent organ rejection in transplant patients. By dampening the immune response, Tacromus works in conjunction with other treatments to enhance the acceptance of transplanted organs, such as kidneys, livers, or hearts. This essential medication plays a crucial role in post-transplant care, as it minimizes the risk of the body rejecting the new organ. However, patients should be aware that using Tacromus may lead to potential side effects, including increased susceptibility to infections and other complications associated with immune suppression. It is vital for individuals taking this medication to be monitored closely by healthcare providers to ensure optimal management of their health. As with any treatment, discussing your medical history and any existing conditions with your doctor is important before starting Tacromus. With proper adherence to guidelines and medical advice, Tacromus 1 mg can significantly improve the success rates of organ transplants and enhance the quality of life for many patients.
Active Pharmaceutical Ingredient
Uses
• Tacromus 1 mg capsule is primarily utilized to prevent organ rejection in patients who have undergone transplants. By suppressing the immune response, Tacromus helps ensure that the body does not attack the newly transplanted organ. This is crucial for the long-term success of the transplant. It allows patients to maintain better organ function and overall health.
• In addition to transplant rejection prevention, Tacromus 1 mg capsule can also be employed in certain autoimmune conditions. By moderating the immune system's activity, it can help manage symptoms associated with these disorders. This use underscores the versatility of Tacromus in addressing various immunological challenges. Patients may experience improved quality of life as a result of this treatment.
• Tacromus 1 mg capsule is often prescribed in conjunction with other immunosuppressive agents for a synergistic effect. This combination therapy can enhance the overall efficacy in preventing organ rejection. Healthcare providers may tailor the treatment plan to the individual needs of the patient, ensuring optimal outcomes. The strategic use of Tacromus in these scenarios highlights its importance in transplant medicine.
• Post-transplant, patients taking Tacromus 1 mg capsule typically require regular monitoring to assess the effectiveness of the medication. Adjustments may be made based on individual responses to the treatment. This ongoing evaluation helps ensure that Tacromus continues to provide adequate protection against rejection. Ultimately, it supports the goal of maintaining a healthy, functioning organ post-transplant.
Benefits
Tacromus prevent the rejection of transplanted organs, such as the kidney, liver, and heart. It works by suppressing the immune system, which reduces the risk of the body rejecting the transplanted organ. Tacromus 1 Capsule may also be effective in treating certain autoimmune disorders, such as lupus, sarcoidosis, and myasthenia gravis. Tacromus Capsule is less likely to cause infections compared to other immunosuppressive drugs. Tacromus 1 mg Capsule can be used in combination with other immunosuppressive medications, such as cyclosporine, to increase its effectiveness.
Side Effects
Like all medications, Tacromus 1 mg Capsule may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Pain or burning when you urinated
• dark urine
• Yellowing of the skin or eyes
• Loss of muscle control
• Confusion
• Thinking problems
Common Side Effects
• Diarrhoea
• Nausea
• Vomiting
• Stomach pain
• Headache
• Rash
• Fever
• Dizziness
• Sore Throat
How To Use
Tacromus on an empty stomach, at least 1 hour before or 2 hours after eating. The exact dosage and duration of treatment will be determined by a doctor and will depend on the individual's condition and response to the medication. It's very important to take Tacromus Capsule exactly as prescribed by your doctor and not to change the dose or stop taking Tacromus 1 Capsule without first consulting your doctor. It's also important to keep all appointments with your doctor and lab tests while taking this Tacromus to check your progress and monitor for side effects.
Safety Advice
• Alcohol: Drinking alcohol while taking Tacromus Capsule is not recommended. Alcohol may increase the risk of side effects or interfere with the effectiveness Tacromus 1 Capsule. Before drinking alcohol while taking any medicine, it is best to talk to your doctor or pharmacist.
• Kidney: Patients with kidney disease should use Tacromus Capsule with caution. It is important that patients with kidney disease monitor their kidney function closely while taking Tacromus 1 mg and report any unusual symptoms or changes in kidney function to their doctor or health care professional. The dose of Tacromus 1 mg Capsule may need to be adjusted in patients with kidney disease.
• Breastfeeding: Breastfeeding is not recommended while you are taking Tacromus 1 Capsule. It is possible that Tacromus may pass into breast milk and cause harm to the baby. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed if you are breastfeeding and taking Tacromus. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Liver: Patients with liver disease should use Tacromus 1 mg Capsule with caution. It is important that patients with liver disease monitor their liver function closely and report any unusual symptoms or changes to their doctor. The dose for Tacromus 1 Capsule may require adjustment in patients with liver disease.
• Pregnancy: The use of Tacromus during pregnancy may not be safe, as there is some evidence from animal studies that it may harm the developing foetus. You must talk to your doctor about the potential risks and benefits of taking Tacromus 1 mg Capsule while pregnant. Your doctor can help you make the best decision for you and your baby.
• Driving: Tacromus 1 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Tacromus 1 mg Capsule.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.